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lilt is the responsibility of every surgeon ... to moni-
tor his experience with care. Onlythose surgeons with
acceptable results are ultimately qualified."I Although
this quotation comes from an editorial regarding
carotid surgery, it is undoubtedly true for all kinds of
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vascular and endovascular procedures. Carefully per-
formed single-centre audits are obviously of value,
but larger registries enabling comparisons between
centres, between treatments, and the study of time
trends have an even higher impact and should be even
more reliable. (See also Recommendation 77, p SI50).
Besides specific registries, such as the Vietnam
Vascular Registry? a very early experience came from
the Cleveland Vascular Society, reporting a large-scale
computerised registration.' More recent registries
have been reported from the Society for Clinical
Vascular Surgery- and the Upstate New York Vascular
Society," More recent experiences come from
Scandinavia with the Swedish Vascular Registry
(SWEDVASq starting in 1987, followed by the FINN-
VASC, the Danish KARBASE, and the Norwegian
NORKAR.
An important difference between the Scandinavian
and North American registries reported above is that
the former are intended to cover entire countries.
Regarding SWEDVASC, this was accomplished from
early 1994 after a successive increase of the number of
hospitals from its initiation in 1987.6 Recently, experi-
ences have been presented from a New Zealand vas-
cular registry, from Northern Ireland and from The
Netherlands (personal communication).
D 4.15.1
Problems With Vascular Registry Data
Limitations may be that long-term results are not eas-
ily obtained. Both FINNVASC and the Danish registry
have found data after 30 days difficult to retrieve.7,8.9,IO
The Swedish Vascular Registry has a I-year follow-up
rate after surgery for chronic limb ischaemia of 92%,
whereas endovascular procedures are less frequently
reported. There is an apparent risk that patients not
followed-up are worse than those who are followed-
up. In a study of femoral distal bypass procedures,
12% were lost to follow-up. Compared with followed-
up patients, those lost to follow-up had mortality rates
of 29% versus 19% and patency rates of 43% versus
68%.11 Also, a Danish follow-up has convincingly
shown that patients lost to follow-up had a signifi-
cantly increased rate of graft thrombosis, limb ampu-
tation, and death." On average the I-year follow-up
rate in SWEDVASC now exceeds 90%. Longer-term
follow-up would be beneficial but is not realistic.
Conversely, in countries in which it is possible to con-
nect a national registry to a population registry, long-
term mortality rates would at least be achievable. This
has been used in studies based on outcome in the
SWEDVASC registry.13
Treatment of Critical Limb Ischaemia S221
One problem is that epidemiology data are not eas-
ily retrieved, because nonintervention cases and
amputations are not recorded in current registries.
Another drawback is that if all operative details are
considered important, a registry protocol has to be
extensive, and this can be cumbersome. Compromise,
therefore, has to be the solution, which means that
uniformity, for instance using Reporting Standards,
has not yet been possible.IU5,16
D 4.15.2
Advantages of Vascular Registries
Advantages of vascular registries include that sur-
geons frequently receive feedback, initiate profession-
al debate, improve self-assessment, and develop better
decision making. One example is the accumulation of
data from treatment of ALI, which has expedited a
change from hazardous thrombectomies to more rea-
sonable thrombolysis.s A registry may be a good guide
to identify accumulation of "sentinel events" that
need further investigation; for example, although
there is a risk of myocardial infarction after surgery for
intermittent claudication, the risk of this or amputa-
tion is higher after other kinds of vascular surgery. A
vascular registry may allow deviations from stan-
dards to be detected more quickly, and quality
improvement measures then may be initiated.
Important questions have been raised concerning
the validity and reliability aspects of a registry. This
has been discussed after the 10-year experiences of the
SWEDVASe.6 The concern is primarily whether all
procedures have been included in the registry,
whether all patients are followed-up, and whether the
data included are correct and complete. As described,
unfavourable results are reported less frequently than
favourable results, which is a drawback. For example,
patency rates of 70% to 90% have been reported for
femoral distal bypass after 1 year. In a recent, fully
audited study of more than 500 patients, the true
patency rate was less than 60%.J7 A reasonable expla-
nation may be that single centres may have different
case mixes or that patients arc lost to follow-up.
Whether all data need to be included is a matter of
debate. One of the difficult issues is to have risk fac-
tors reported. It was recently shown that smoking
increased the risk for both reoperation in ALI and elec-
tive aortic aneurysm surgery. Hypertension had the
same effect in emergency aortic aneurysm surgery.IS It
is therefore assumed that risk factors' are of great
importance in a full audit.
Registries are of value to study time trends and dif-
ferences between geographical areas. From the
Swedish Vascular Registry, it is evident that as much
as 49% of all procedures are performed for CLI, but a
larger proportion than expected is performed for Ie.
The quotient IC/CLI varies between health care
regions from 0.62 to 1.23. From 11.7 to 37.0 procedures
per 100,000 inhabitants are performed annually for
CLI and reported to SWEDVASC-a figure lower than
expected given that the proportion of new CLI
patients ranges from 500 to 1,000 per 100,000 popula-
tion annually.
Endovascular procedures are used increasingly. On
average, 47% of interventional procedures registered
in the SWEDVASC between 1987 and 1996 were per-
formed using endovascular techniques. In the proxi-
mal (aortoiliofemoral) region, endovascular proce-
dures now constitute 73% of cases, compared with
30% in 1987. For the distal (femoropopliteal) above-
knee region, corresponding increases are from 25% to
50%. For CLI, infrainguinal procedures constitute 88%
of all procedures. The 3D-day amputation and mortal-
ity rates range between 7% and 11% without signifi-
cant differences between the various locations of
lesions for surgical procedures. In a follow-up of
almost 5,000 surgical and endovascular procedures
below the groin for CLI, the late survival rate was cal-
culated. The 6-year cumulative survival rate was sig-
nificantly higher for patients with a patent reconstruc-
tion after 1 year and also for those who did not have
amputations, despite an occluded reconstruction,
compared with those who undenvent an amputation.
This was particularly true after surgery, whereas after
PTA only a patent segment indicated a better cumula-
tive survival rate.P
National vascular registries have a great impact on
the attitude of vascular surgeons, provided that they
are involved in the process. Discussions and debates
regarding the outcome of the registry variables might
help to understand drawbacks of treatments or vari-
ations in outcomes. At the very least, it is helpful to
find out whether treatments are of value for a partic-
ular patient category, for instance, whether a distal
bypass procedure is of any lasting benefit for the
patient or whether severe complications to carotid
surgery might reduce the value of carotid endarterec-
tomy.
Critical Issue 43: Influence of vascular registries on
r-atient management
There is a need to establish how vascular registries
benefit the management of patients with peripheral
arterial disease on a population basis.
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The treatment modalities considered here are not nec-
essarily confined to CLI patients but are sometimes
also used in claudicants.
D 4.16.1
Transfusion of Ultraviolet Irradiated Autologous Blood
This technique is widely used in patients with PAD in
all stages, mostly in eastern countries of Europe and
Russia. Photohaemotherapy consists of ultraviolet
radiation of autologous blood. Although a few uncon-
trolled studies showed an improvement of rheological
properties of the blood, there is no controlled prospec-
tive study in patients with IC or CLI showing a clear
clinical benefit for the treated patients.'
D 4.16.2
Hyperbaric Oxygen
The initial reports on the use of hyperbaric oxygen in
patients with early gangrene of the legs were encour-
aging, because relief of pain was obtained and ampu-
tations could be postponed, even for several yearsP
In an uncontrolled study, 18% of diabetic patients with
ulcers refractory to conventional treatment had com-
plete healing, but all made at least a fair response.
Seventy-five percent of atherosclerotic ulcers in nondi-
abetic patients improved sufficiently to allow patients
to return horne and resume daily activities.' The
longest and largest experience was reported by
Fredenucci,? who collected data on more than 2,000
patients treated in over 70,000 sessions between 1966
and 1983. Relief of rest pain and healing of limiting
ulcers was observed in one third of patients after 4 to
6 weeks of treatment. The therapy is cumbersome, and
it is also unclear to what extent the clinical results can
be attributed to concomitant therapy, including
heparin infusion. All of the reported studies were
uncontrolled. This treatment cannot be recommended
until prospective controlled trials have shown it to be
beneficial.
Local treatment with hyperbaric oxygel/
Although local hyperbaric oxygen with topical hyper-
baric oxygen chamber technique has undergone real
waves of enthusiasm, its use for treatment of ulcers
due to CLI or for stump healing problerns.s? remains
to be more clearly demonstrated by randomised clini-
cal trials.
